Ibrutinib-Induced Skin Rash

Ibrutinib-Induced Skin Rash

Bibliographic Details
Main Authors:	Sudhir Kirar, Ajay Gogia, Ritu Gupta, Saumyaranjan mallick
Format:	Article
Language:	English
Published:	Galenos Publishing House 2021-02-01
Series:	Turkish Journal of Hematology
Subjects:	ibrutinib skin rash cll
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-96630

Similar Items

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge
by: Sudhir Kumar, et al.
Published: (2020-11-01)

Imbruvica (Ibrutinib) induced subcutaneous hematoma: A case report
by: Chinmay Jani, et al.
Published: (2021-03-01)

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
by: Ujjani C, et al.
Published: (2020-08-01)

Ibrutinib dose modifications in the management of CLL
by: Camille Hardy-Abeloos, et al.
Published: (2020-06-01)

Ibrutinib-induced cardiomyopathy
by: Htay Htay Kyi, et al.
Published: (2019-01-01)

Ibrutinib-associated skin toxicity: a case of maculopapular rash in a 79-year old Caucasian male patient with relapsed Waldenstrom’s macroglobulinemia and review of the literature
by: Anders Bisgaard Jensen, et al.
Published: (2017-04-01)

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
by: Keisuke Kidoguchi, et al.
Published: (2021-02-01)

Carbamazepine-Induced Skin Rash
by: J Gordon Millichap
Published: (1993-07-01)

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
by: Baustin M. Welch, et al.
Published: (2023-12-01)

Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia
by: Omar Elaskalani, et al.
Published: (2022-11-01)

Escitalopram-induced skin rash: Dermatitis medicamentosa
by: Sangha M Godi, et al.
Published: (2022-01-01)

The relationship between skin rash and outcome in dengue
by: Ajay Kumar Mishra, et al.
Published: (2018-01-01)

Aripiprazole-induced skin rash
by: Santanu Nath, et al.
Published: (2016-01-01)

Olanzapine-induced skin rash: A case report
by: Mansi Shah, et al.
Published: (2019-01-01)

Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients
by: Tamara Mateu-Albero, et al.
Published: (2022-05-01)

A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1+ CLL cells
by: Amineh Ghaderi, et al.
Published: (2021-08-01)

A new rapid titration protocol for lamotrigine that reduces the risk of skin rash
by: Yoonhyuk Jang, et al.
Published: (2021-06-01)

Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia
by: Elizabeth M. Muhowski, et al.
Published: (2022-11-01)

The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia
by: Daphne Guinn, et al.
Published: (2017-04-01)

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
by: Richard Lemal, et al.
Published: (2019-08-01)

An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib
by: Fady Gh Haddad, et al.
Published: (2021-01-01)

Investigating the causes of skin rashes in children admitted to Hospital
by: Seyed Mohammad Reza Shokrollahi, et al.
Published: (2018-06-01)

A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States
by: Anthony Mato, et al.
Published: (2023-02-01)

Skin rash and mild bruising: Is montelukast a safe drug?
by: Deep Inder, et al.
Published: (2018-01-01)

Epstein-Barr virus induced skin rash in infectious mononucleosis
by: Yutaro Akiyama, et al.
Published: (2021-01-01)

Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
by: Gabriela Galicia-Vázquez, et al.
Published: (2018-09-01)

Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis
by: Nuttall E, et al.
Published: (2019-07-01)

A combined administration of Aragvādādi kaṣāyam and Syrup Talekt induced skin rashes
by: Manjunath Ajanal, et al.
Published: (2014-01-01)

Unusual case of lamivudine-associated skin rashes in an HIV/AIDS patient: a case presentation
by: Kashif U Khan, et al.
Published: (2017-01-01)

An unusual presentation of acute brucellosis with thrombocytopenia and maculopapular rash
by: O. Alici,1 B. Kasapoglu,2 R. Alkan,2 E. Sarifakioglu,3 R. Akgedik,4 R. Bozalan,2 A. Kosar,5 H. Sahin6
Published: (2007-10-01)

Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data
by: Isaac K, et al.
Published: (2020-03-01)

Plasmodium vivax malaria presenting with skin rash - a case report
by: Syed Ahmed Zaki & Preeti Shanbag
Published: (2011-12-01)

The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
by: Alessandro Noto, et al.
Published: (2021-05-01)

Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia
by: Kevin Y. Chen, et al.
Published: (2020-03-01)

Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report
by: Vassilios Liakopoulos, et al.
Published: (2018-10-01)

The Efficiency of Florabile Syrup on Intensity of Psoriasis Rashes
by: Ameneh Parastegari, et al.
Published: (2021-03-01)

Skin rash with respiratory distress: A report of two cases
by: Satyaki Das, et al.
Published: (2017-01-01)

The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash
by: Amy Sharma, et al.
Published: (2019-01-01)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
by: Nurhilal Büyükkurt, et al.
Published: (2023-06-01)

Multifocal periungual granulation tissue related to ibrutinib therapy
by: Aatman Shah, MD, et al.
Published: (2020-02-01)